-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Germline Pathogenic Variants in DNA Damage Response and Repair Genes and Their Impact on HCT Outcomes in 2008 Patients with Severe Aplastic Anemia, Myelofibrosis and Myelodysplastic Syndrome

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: New Scientific Discoveries
Friday, December 6, 2024, 4:06 PM-4:56 PM

Maryam Rafati, MD, PhD

National Cancer Institute, NIH, Rockville, MD

Disclosures: No relevant conflicts of interest to declare.

<< Previous Presentation | Next Presentation